Timed walk as primary outcome measure of treatment response in clinical trials for HTLV-1-associated myelopathy: a feasibility study

BACKGROUND: To advance the treatment of HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP), randomised controlled therapeutic studies with appropriate and sensitive outcomes are reuired. One candidate outcome is the 10-metre walk test (10MWT), a patient-centred, simple and functiona...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Pilot Feasibility Stud
Glavni autori: Martin, Fabiola, Inoue, Eisuke, Cortese, Irene C. M., de Almeida Kruschewsky, Ramon, Adonis, Adine, Grassi, Maria Fernanda Rios, Galvão-Castro, Bernardo, Jacobson, Steven, Yamano, Yoshihisa, Taylor, Graham P., Bland, Martin
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2015
Teme:
Research
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5153909/
https://ncbi.nlm.nih.gov/pubmed/27965813
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40814-015-0031-1
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items